chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received dose after 30-day Use By Date or after manufacturer date of expiry) in a 20-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013H21B, 022c21A and 014c21a) for COVID-19 vaccination. The patient's past medical history included COVID-19 on 28-Dec-2021. On 28-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 24-Mar-2022, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 24-Mar-2022,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received dose after 30-day Use By Date or after manufacturer date of expiry). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient received dose after 30-day Use By Date or after manufacturer date of expiry) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 28-Dec-2021, SARS-CoV-2 test: positive (Positive) Positive. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were reported. The vial was initially stored in the refrigerator was on 9 March 2022 and the date of administration of vaccine was on 24 march 2022. The vial did not undergo any temperature excursion. It was reported that patient had no allergies (medications, food and other products). It was reported that no other vaccines given within 1 month prior to Moderna COVID-19 vaccine. Adverse event did not caused patient to seek medical care. The patient had not experienced any similar event in the past. No treatment medications were reported.
Hospitalization for shortness of breath from COVID-19 Pneumonia on dates 5/5/2022- 5/10/2022.  Treated with dexamethasone, aformoterol nebulizer BID, budesonide 0.5mg inhaled BID, Symbicort Inhaler 2 puffs BID, baricitinib 2mg PO daily, vitamin C 1,000 mg PO daily, vitamin D 25 mcg PO daily, zinc 50 mg PO daily.
Scabbing at the injection site/the scab grows bigger and bigger and then falls off; Painful; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SCAB (Scabbing at the injection site/the scab grows bigger and bigger and then falls off), PAIN (Painful) and HAEMORRHAGE (it bleeds a little both then grows) in a 52-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022C21A) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes. Concomitant products included INSULIN GLARGINE (SEMGLEE), AMYLIN [AMLINTIDE], LISINOPRIL and ESCITALOPRAM OXALATE (LEXAPRO) for an unknown indication.   On 05-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE SCAB (Scabbing at the injection site/the scab grows bigger and bigger and then falls off), PAIN (Painful) and HAEMORRHAGE (it bleeds a little both then grows). At the time of the report, VACCINATION SITE SCAB (Scabbing at the injection site/the scab grows bigger and bigger and then falls off), PAIN (Painful) and HAEMORRHAGE (it bleeds a little both then grows) had not resolved.            The action taken with mRNA-1273 in response to the events were not applicable.  No treatment medication was provided.   Most recent FOLLOW-UP information incorporated above includes: On 30-Jul-2021: reporter declined for further follow up
pt was exposed to a child vaccinated w/varicella vax;2wk post exposure pt devel vesiculopustular rashes on an erythematous base;
I asked for my 4th COVID booster shot during a doctor's appointment and one week later, my doctor's office notified me that I had not been given the correct vaccine.  I received the first COVID vaccine that was available two years ago -- the first shot.  I should have received the 4th booster, the Bivalent.  I was told that I am not protected from the current strains of COVID and that I have to wait 60 days before getting the correct 4th booster.
he cannot move his arm; shoulder pain where he received the vaccine; This spontaneous case was reported by a consumer and describes the occurrence of MOBILITY DECREASED (he cannot move his arm) and VACCINATION SITE PAIN (shoulder pain where he received the vaccine) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MOBILITY DECREASED (he cannot move his arm) and VACCINATION SITE PAIN (shoulder pain where he received the vaccine). At the time of the report, MOBILITY DECREASED (he cannot move his arm) and VACCINATION SITE PAIN (shoulder pain where he received the vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was unknown by the reporter.  Treatment information was not provided.  Patient had reported that He cannot live like this.
About 10 minutes post vax pt broke out in hives. His entire body covered, legs, torso, face. Treated with 50 ml Benadryl given IM. Temperature 98.1. Hives gone a 12:25 pm, dismissed to home at 12:40 PM.
I had blood work on the 11th, 5 days after vaccine.  I am normally very healthy, vegetarian.  My glucose levels are at 121 and my Triglyceride level is at 393.   Both are considered high according to results.  I have also been a little short of breath at times...a sense on indigestion, which I rarely get but seem to have it after every meal.  I am not sure if this is related to my shot but I wanted to be aware of any adverse reactions.  I didn't see any posted on this site.  Why?
I was calling to get on the pregnancy something list; This spontaneous pregnancy case was reported by a consumer and describes the occurrence of PREGNANCY (I was calling to get on the pregnancy something list) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. Last menstrual period and estimated date of delivery were not provided. On an unknown date, the patient experienced PREGNANCY (I was calling to get on the pregnancy something list). At the time of the report, PREGNANCY (I was calling to get on the pregnancy something list) outcome was unknown. Not Provided          No relevant concomitant medications were reported. No treatment information was provided.    Reporter did not allow further contact; Sender's Comments: This is a case of product exposure during expected pregnancy with no associated AEs for this female patient. Patient will continue to be contacted for further monitoring of AEs during the pregnancy.
dry cough, chills, and at that time he tested positive to COVID-19.  symptoms have progressively worsened with diarrhea, fever with T-max of 101°, loss of taste and smell sensations
Case number PHEH2013US011950, is an initial spontaneous report received from a pharmacist on 30 May 2013. This report refers to a 62-year-old male patient. His medical history and concomitant were not reported. He was vaccinated with MENVEO (batch number: not reported, expiry date: Dec 2013) on 24 May 2013. No adverse event was reported following this administration error.
Right upper arm red, swollen and warm to touch. Due to severity pt treated with Keflex.
pt recv vax;rt eye swollen shut;to MD;stated rxn to something unsure of cause;dph given;was irritable; kept waking up during noc; T 103; recv apap; T came down w/ apap;
pain when she breath deeply; not feeling well; body aches; headaches; This spontaneous case was reported by a consumer and describes the occurrence of PAINFUL RESPIRATION (pain when she breath deeply), MALAISE (not feeling well), MYALGIA (body aches) and HEADACHE (headaches) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 066h21a, 046a21a and 023m21a) for COVID-19 vaccination.     No Medical History information was reported.   On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 18-Jan-2022, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 18-Jan-2022, the patient experienced PAINFUL RESPIRATION (pain when she breath deeply). 18-Jan-2022, the patient experienced MALAISE (not feeling well), MYALGIA (body aches) and HEADACHE (headaches). At the time of the report, PAINFUL RESPIRATION (pain when she breath deeply), MALAISE (not feeling well), MYALGIA (body aches) and HEADACHE (headaches) had not resolved.            No concomitant medication information provided. No treatment information provided.   Most recent FOLLOW-UP information incorporated above includes: On 20-Jan-2022: Follow-up received contained no new information.
Site: Pain at Injection Site-Medium, Systemic: Body Aches Generalized-Severe, Systemic: Chills-Severe, Systemic: Exhaustion / Lethargy-Severe, Systemic: Fever-Severe, Systemic: Headache-Medium, Systemic: Unable to Sleep-Severe, Systemic: Weakness-Severe, Additional Details: Started about 9 hours after and lasted about 12-14 hours and the arm is still sore.
fever of 100.5; Shortness of breath; Jaw achy; Neck hurting; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (Shortness of breath), PAIN IN JAW (Jaw achy), NECK PAIN (Neck hurting) and PYREXIA (fever of 100.5) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination.     Concomitant products included BUDESONIDE, FORMOTEROL FUMARATE (SYMBICORT) for an unknown indication, OMALIZUMAB (XOLAIR).   On 03-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Feb-2021, the patient experienced DYSPNOEA (Shortness of breath), PAIN IN JAW (Jaw achy) and NECK PAIN (Neck hurting). On 04-Feb-2021, the patient experienced PYREXIA (fever of 100.5). At the time of the report, DYSPNOEA (Shortness of breath), PAIN IN JAW (Jaw achy), NECK PAIN (Neck hurting) and PYREXIA (fever of 100.5) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 100.5 F.         Treatment details included Paracetamol and Naproxen.
severe stroke-like symptoms:  passed out cold on the bathroom floor, crawled into my room.  would have called 911 but could not move.  extreme pain.  next day on the way back from an unrelated doctor appointment i threw up out the car window!   since then i have had heart problems with palpitations, occasional anxiety attacks and sometimes feel simultaneous heart irregularities and nearly passing out.  my stomach was screwed up for a long time too but now i mostly notice the heart irregularities.  no way would i ever recommend that anyone do that to themselves!  i told the new guy at my local facility about the symptoms and he suggested that i was crazy and offered me SSRIs!  i could have punched him in the mouth! .  is that how MDs are being brainwashed to treat people now?  i immediately quit that idiot.
Arm sore/a little tender; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm sore/a little tender) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037K20A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Jan-2021, the patient experienced PAIN IN EXTREMITY (Arm sore/a little tender). At the time of the report, PAIN IN EXTREMITY (Arm sore/a little tender) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant products were reported. No treatment information was reported by the reporter.
Information has been received from a lawyer regarding a case in litigation concerning a female patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. On or about 03-DEC-2012, the patient was inoculated with ZOSTAVAX (lot number, dosage and route of administration not provided), by a physician as recommended for routine adult health maintenance and for the prevention of shingles. The ZOSTAVAX did not prevent shingles as intended, and the patient subsequently contracted a persistent strain of herpes zoster. On or about 30-APR-2016, the patient was treated by a physician for a persistent and severe vesicular rash, which was diagnosed as shingles. The patient has been prescribed valacyclovir (VALTREX) and mupirocin (BACTROBAN)  for management of her painful symptoms and chronic pain. As a direct and proximate result of the ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. The outcome is unknown. Additional information has been requested.
Pt reports had significant vomiting day after HPV with all three administrations.  3/23/09 Received PCP medical records of 9/19/07- FINAL DX: viral gastroenteritis Records reveal patient experienced mild depression, received counseling & improved.  Missed several days of school secondary to severe menstrual cramping.  RTC 4/28/08 w/epigastric pain after eating, nausea, diarrhea x 5 da.  Dx w/viral gastroenteritis.  No further documentation of s/s.
Vaccine administered to female person age 17yrs, 6month old. No adverse events noted. No parental consent prior to administration of vaccine. Follow calls made to parent.  Asked them to call back for more information or for additional concerns. No return call as of report.
Moderna COVID-19 Vaccine EUA  obtained at 14:50 on 12/29/2020. Severe headache onset about 4-5 hours post vaccine, continued until about 24 hours post vaccine. Headache included light and noise sensitivity, accompanied by extreme fatigue and myalgias. Unable to work for day after vaccine. Headache subsided and able to return to work 48 hours post vaccine.
This case was reported by a pharmacist and described the occurrence of injection site redness in a 40 year old female subject who was vaccinated with influenza virus (Fluarix, GlaxoSmithskline) for prophylaxis. The subject's medical history included allergy to nsaids, cellulitis, dyspareunia,dysthymia, gastroesophageal reflux disease, hyperlipidemia, knee osteoarthritis and neck abscess. Concurrent medications included Moxifloxacin hydrochloride (Moxifloxacin), Rosuvastatin, calcium (Crestor), Vicodin, Lormetazepam, Omeprazole (Prilosec), Nortriptyline, Trazodone and Capsaicin (Capsaicin cream). The subject had received influenza virus vaccine in previous years with no subsequent adverse events. On 29, January 2007 the subject received unspecified dose of Fluarix in the right deltoid. On 29, January 2007, the subject also received and administration of tetanus and diphtheria toxoids adsorbed (Adventis Pasteur) at an unspecified site of injection. On 01, February 2007, 3 days after vaccination with Fluarix, the subject experienced redness and hardening at the injection site of Fluarix "in an area if 8 mm, " chest pain, chest congestion, and vomiting. The redness and hardening at the injection site resolved on 06 February 2007. On 12 February 2007, the subject was seen at a physician's office and the chest pain , chest congestion and vomiting were resolved. The pharmacist considered the events were possible related to vaccination with Fluarix. Follow-up information received on 26, February 2007 indicated that the event actually resolved by 06 February 2007 as opposed to the originally reported date of 12 February 2007. The events were not considered to be life threatening. A history of smoking , 1 pack per day was reported. No additional information was reported.
Chills, headache, sore muscles, stomach upset.  Duration of about 24 hours
Had 3rd Anthrax in lt arm and three days later developed red macular rash at site, Pruritus at site of rash. Treated with Motrin and antihistamines.
Pt said they felt pain in left arm upon needle insertion like it "hit a nerve".  She reports that her fingers were tingly but she felt well enough to leave the immunization room.  Upon walking to the waiting area, she then felt faint and lowered herself to the ground where her spouse said she lost consciousness for about 5 seconds. She was given a cold pack and cold water and recovered after about 10 minutes.
Immediate hypersensitivity reaction to MMR vacc. w/ spreading erythema and urticarial lesion at site of injection. She was comfortable & breathing easy - happy. Cool compress applied. Parents instruc. to begin BENADRYL for next 24 hours. 5/9 call w/ MOC=patient was fine.
Very positive and unusual response to the third dose of the Moderna COVID19 vaccine/Unusual excellent eye site/ Vision had significantly improved compared to previous visitations; This spontaneous case was reported by a consumer and describes the occurrence of THERAPEUTIC RESPONSE UNEXPECTED (Very positive and unusual response to the third dose of the Moderna COVID19 vaccine/Unusual excellent eye site/ Vision had significantly improved compared to previous visitations) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 039D21A, 048A21A and 044A21A) for COVID-19 vaccination.     The patient's past medical history included Wet macular degeneration. Concurrent medical conditions included Immunocompromised and Rheumatoid arthritis. Concomitant products included METHOTREXATE for an unknown indication.   On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 10-Jun-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 09-Oct-2021, the patient experienced THERAPEUTIC RESPONSE UNEXPECTED (Very positive and unusual response to the third dose of the Moderna COVID19 vaccine/Unusual excellent eye site/ Vision had significantly improved compared to previous visitations). At the time of the report, THERAPEUTIC RESPONSE UNEXPECTED (Very positive and unusual response to the third dose of the Moderna COVID19 vaccine/Unusual excellent eye site/ Vision had significantly improved compared to previous visitations) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 18-Oct-2021: Significant follow up appended: date for doses added, lot/batch no added for doses,  con med added
Vaccine given on 11/17/22. First 15 min - OK. Nothing that day - no sore arm. Some lethargy. Woke up next day - right hip soreness 2nd day - both knees - sore. 3d later - woke up with (R) elbows, (B) knees, (R) hip hot, painful to touch, swollen, edematous went to urgent care on 11/21 (Treated with prednisone by me later on 11/21) Now on 11/29 - has
Pharmacist states they gave full doses for boosters instead of half doses. This spontaneous case was reported by a pharmacist and describes the occurrence of OVERDOSE (Pharmacist states they gave full doses for boosters instead of half doses.) in an 84-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040D21A) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Oct-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Oct-2021, the patient experienced OVERDOSE (Pharmacist states they gave full doses for boosters instead of half doses.). On 25-Oct-2021, OVERDOSE (Pharmacist states they gave full doses for boosters instead of half doses.) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant and treatment information were reported by the reporter
Bad headache on Left side of head where ear is toward the back. Confusion, Dizziness, , Light headed, Tingling and numbness from left eye to jaw. Drooping of left eye and lips. Memory and processing information issues. One month later still some head pain off and on and numbness around left eye. Still have memory and processing issues. I've never had any other prior issues with the head or face. No falls or activities such as boxing
nausea; severe pain in legs and back; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (severe pain in legs and back) and NAUSEA (nausea) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Feb-2021, the patient experienced PAIN IN EXTREMITY (severe pain in legs and back). On an unknown date, the patient experienced NAUSEA (nausea). At the time of the report, PAIN IN EXTREMITY (severe pain in legs and back) and NAUSEA (nausea) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided. No treatment medications provided by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 13-Jul-2021: Non-Significant FU- Declined consent for further FU
Sore Arm; Body Soreness; This is a spontaneous report from a contactable consumer or other non hcp.     A female patient of an unspecified age received bnt162b2 (BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; Solution for injection Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date as unknown, single for covid-19 immunisation. The patient medical history and concomitant medications was not reported. It was reported that, the patient experienced sore arm, body soreness on an unspecified date with outcome of unknown.   Information about batch/lot number not available. Further information has been requested.  Additional Context:  The report is cross referenced to report ID:(#)  When calling to report his own events the caller mentions that his wife also had the vaccine and she had a sore arm and some body soreness but she wasn't sick or anything like that.  He declines to complete a report for his wife. States it was just a normal reaction and she was back to normal the next day.   Communication:  Caller declined to complete report.  Report 2 of 2.  The report is cross referenced to report ID: (#)
SEVERE PERSISTENT HEADACHE, FEVER, INANITION,NUMBNESS, TINGLING , FATIGUE, EFFORT INTOLERANCE, VISUAL CHANGES, AND GENERALLY UNWELL